Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy
Clinical trial NCT02503332 · COMPLETED
Trial details
- NCT number
- NCT02503332
- Sponsor
- Apellis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-24
- Primary completion
- 2017-07-14
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.